During penile pharmacotesting, anxiety may overcome complete smooth muscle relaxation and lead to false positive diagnosis of organic male erectile dysfunction (ED). We tested the ef®cacy and safety of re-dosing of PGE 1 alone versus combination of PGE 1 and the a 1,2 -blocker phentolamine (PHE) to improve an incomplete pharmaco-induced erection during color-power-Doppler (CPD) sonography. 116 consecutive impotent patients were submitted to CPD and injected with 10 mg PGE 1 plus audiovisual sexual stimulation. Clinical evaluation of rigidity and CPD parameters were normal in 26 patients while in the remaining they were upgraded in 15% and 35% after redosing of 10 mg PGE 1 alone and 10 mg PGE 1 plus 1 mg PHE, respectively (P`0.05); furthermore, in these latter patients CPD studies showed increased visualisation of distal rami®cations of helicine arterioles. The ®nal diagnosis was changed in those patients who responded to re-dosing with no differences in the occurrence of prolonged erections between the two treatments. We conclude that re-dosing of PGE 1 aPHE mixture is a safe and effective procedure to maximize erectile response during dynamic CPD sonography and has a better diagnostic sensitivity than re-dosing of PGE 1 alone.
Introduction
Penile erection is a psycho-neuro-endocrine and vascular phenomenon produced by three simultaneous events: (1) arterial dilation with subsequent increase in¯ow; (2) lacunar space dilation with ®lling of the corpora cavernosa; and (3) decreased venous out¯ow. 1 Color-power-Doppler (CPD) sonography has been gaining more importance in the initial evaluation of penile circulation in male erectile dysfunction (ED). 2 ± 5 The aim of this procedure is to achieve a full penile erection and complete smooth muscle relaxation by an intracavernous injection (ICI) of several vasoactive drugs to fully evaluate both the morphodynamic features of the cavernous arteries and to obtain information about the cavernous veno-occlusive mechanism. 6 However, the choice of a single intracavernous vasoactive agent for diagnostic purposes has not yet been standardized. Several drugsÐpapaverine, phentolamine, prostaglandin-E 1 (PGE 1 ), vasointestinal peptide and moxysiliteÐhave been used alone or in combination. 7Y8 Since the veno-occlusive mechanism is highly susceptible to psychological factors and to the type and dosage of the vasoactive agent, some authors used to combine ICI with audiovisual sexual stimulation (AVSS) and, when needed, re-dosing of PGE 1 after 15 ± 20 min from the ®rst ICI 5 in order to maximize penile erection. We have demonstrated that high levels of state-anxiety, measured by psychological tests, are often present in newly diagnosed impotent patients and may lead to an incomplete pharmacoinduced erection with vasoactive agents. 9 The addition of the a-blocker phentolamine to a maximal dose of PGE 1 often improves the erection in non-organic male ED assessed by the clinical evaluation of penile axial rigidity in an outpatient setting. 9 In the present study, we compared the diagnostic ef®cacy and safety of re-dosing of PGE 1 alone versus combination of PGE 1 and the a 1,2 -blocker phentolamine (PHE) during CPD sonography evaluation of hemodynamic parameters and helicine arterioles morphology in subjects not responding to a ®rst challenge with PGE 1 .
Materials and methods
From October 1997 to August 1998, 116 consecutive patients (mean age 49.8 AE 1.3 y s.e., range 19 ± 78 y) with ED of at least six months duration were seen at our impotence clinic. A detailed sexual history was taken and a physical examination was performed. Laboratory tests (serum glucose, glycosylated hemoglobin, cholesterol, prolactin and free testosterone) were carried out to identify the presence of the main risk factors for impotence. 1 After giving an informed consent to the sonographic study, patients were positioned supine on an examination couch in a quiet and semi-obscured room. The sonographic probe was placed on the lateral sides of the penis at the level of the penoscrotal junction. A preliminary ultrasonographic scan of the cavernous bodies starting from the crus and continuing distal towards the glans was carried out in the¯accid state to identify possible areas of ®brosis or scarring. Evaluation of the cavernous arteries was performed with a dedicated machine (AU4, Esaote) using colorpower Doppler software. Ultrasonographic linear probes with 7.5 and 10 MHz frequencies were used according to penile size, while Doppler frequency and pulse repetition frequency were set on 6.5 and 700 Hz, respectively, and varied during the test as needed. During CPD sonography the length of the sample volume was maintained at 2 mm in all patients. After injection, color Doppler recording of the cavernous arteries was performed at the penoscrotal junction along an arterial segment corresponding to a Doppler angle of 55 degrees to obtain comparable data among different patients. 3 Flow parameters were continuously recorded by one of us (AA) and included peak systolic velocities (PSVs), end diastolic velocities (EDVs) and the resistive index (RI) before and after (phase I) a standardized pharmacostimulation with 10 mg PGE 1 and subsequent audio-visual sexual stimulation (AVSS). 3 The cavernous arteries¯ow and helicine arterioles morphology and their¯ow pattern were recorded when possible 3, 5, 10 and 15 min after the injection. 10 At the end of this phase, the patient was asked to stand up and erection was graded subjectively by an examinator (CM) who was unaware of the¯owmetric results, according to previously published procedures. 9 If the patients achieved a full erection the test was stopped at this phase. The remaining patients were asked to compare the present erection with that usually obtained during sexual activity and, if the latter was not adequate they were randomized to a second injection (re-dosing) of either PGE 1 10 mg (Phase 2a) or PGE 1 10 mg plus phentolamine 1 mg (Phase 2b) and repeat AVSS. 10 CPD scan of the cavernous arteries and helicine arterioles was repeated and the hemodynamic parameters as well as the degree of erectile response were measured at the time of maximum rigidity obtained during the test. The two phases of the test are summarized in Figure 1 .
During the various phases of Doppler recording, the highest value of PSV recorded at any of the established time-points was considered to indicate cavernous artery in¯ow, while the lowest values of EDVs and the highest values of RI were used to determine the integrity of cavernous veno-occlusive mechanism. 1 The patients were observed for at least 120 min after the end of the examination. If erection exceeded this time, an ICI of 500 mgaml metharaminol was administered every 5 min until the detumescence was achieved. Student t-test for unpaired data was used for statistical analysis of the results. Before performing the comparison between the two different sessions the possibility of a period effect was investigated using a two-sample t-test to compare the differences between the periods in the two groups of patients. 11 Then, the comparison between proportions was used to compare the percentage of patients with different erectile responses after phase 2a versus 2b. 9 Data are presented as mean AE s.e.m., unless otherwise speci®ed; P values less than 0.05 were considered to be statistically signi®cant. 
Results
Cavernous arteries in¯ow was considered normal when PSVs were higher than 30 cmasec at the end of dynamic CPD sonography session. 4 Phase 1 of the study allowed to allocate impotent patients in different groups: psychogenic patients with PSVs higher than 30 cmasec, EDVs equal to 0 ± 5 cmasec and RI b 0.90, arteriogenic patients with PSVs lower than 30 cmasec, venogenic patients with EDVs higher than 5 cmasec and RI lower than 0.9 and ®nally, mixed arterious-venogenic patients with either PSVs lower than 30 cmasec and concomitant EDVs higher than 5 cmasec. In these two latter groups, patients were not able to obtain andaor maintain erection for the overall duration of the test. For each patient, average values of at least two recordings on either artery were considered for analysis. The diagnosis of psychogenic ED was made by exclusion criteria when Doppler data indicated normal penile in¯ow and out¯ow and a full erection was obtained at the end of test. After phase 1 of the study, 26 out of 116 patients (22%) obtained a satisfactory erection and stopped the test: 22 had psychogenic (22 out of 36) while the remaining four had arteriogenic (four out of ten) causes of ED. In the venogenic and mixed arteriousvenogenic group none of the impotent men responded with a rigid erection after phase 1 ( Table 1) . The remaining patients (n 90) entered into phase 2 of the study and were randomized into two groups of comparable numberÐ45 patients for the PGE 1 or cocktail re-dose tests (see Figure 2B ).
In the psychogenic group, mean PSVs of right and left cavernous arteries were always higher than 30 cmasec (mean 48.5 AE 4.5). In 22 responders after phase 1, EDVs were equal to zero and RI was equal to 1. 14 patients did not reach complete relaxation and rated their erection poorer than that obtained at home; these patients had EDVs between 1 and 5 cmasec, RI lower than 1, and were classi®ed as non-responders ( Figure 2A ). After randomization to phase 2 of the study, erection was upgraded in three out of seven patients (43%) in phase 2a versus six out of seven patients (86%) in phase 2b ( Figure 2B ). In responders to phase 2, EDVs after re-dosing approached to zero and signi®cantly varied when compared to that recorded during phase 1 (1.1 AE 0.5 versus 4.5 AE 0.2, P`0.05) while the RI approached Figure 3A) . In non-responders to phase 2, no changes of EDVs were recorded compared to phase 1 and CPD sonography showed normal anatomy and caliber of helicine arterioles but only oneatwo order(s) of visible distal rami®cations originating from the cavernous arteries with an acute angle.
In the arteriogenic group, mean PSVs were always lower than 30 cmasec (mean 21 AE 3.7). In responders to phase 1 EDVs were equal to zero and the diagnosis of arteriogenic ED was made. 5 Arterial communications 12 were found in two out of four responders (data not shown). Six non-responders were randomized to phase 2 of the study ( Figure  2A Figure 2B ). Non-responders achieved a full tumescence but not adequate rigidity for vaginal intromission, and showed only one order of distal rami®cations of helicine arterioles, sometimes visible with CPD sonography ( Figure 3B ).
In the venogenic (n 36) and mixed arteriousvenogenic (n 34) groups, mean PSVs were higher than 30 (mean 38.8 AE 3.4) and lower than 30 cmasec (mean 25.6 AE 1.1), respectively. Mean EDVs were always higher than 5 (15.5 AE 4.1 and 14.5 AE 5.3, respectively), and the diagnosis of corporeal venoocclusive dysfunction was made. 13 In both groups, none of the patients achieved rigid erections (RI b 0.9) after phase 1 (Figure 2A ). After phase 2, erection was upgraded in two out of 18 patients (12%) versus six out to 18 patients (39%) in the venogenic group, and in one out of 17 patients (6%) versus four out of 17 patients (21%) in the mixed group in phase 2a and 2b, respectively ( Figure 2B ). In non-responders of both groups, EDVs did not change in phase 2 when compared to phase 1. Responders to phase 2 had a signi®cant decrease in EDVs when compared to phase 1 (4.9 AE 0.9 versus 15.5 AE 4.1 and 3.9 AE 0.8 versus 14.5 AE 4.3, respectively, P`0.05) leading to a RI higher than 0.9 (0.91 versus 0.58 and 0.91 versus 0.49, respectively) but no signi®cant modi®cations in PSVs. Moreover, in both venogenic and mixed groups re-dosing of PGE 1 plus PHE led to the visualization of helicine arterioles with two orders of distal rami®cations at CPD study ( Figures 4B,D) , and to the presence of a semirigid erection. In non-responders to phase 2, EDVs did not differ from phase 1, full tumescence but not adequate rigidity for vaginal intromission was achieved, and CPD study showed a diffuse arteriolar damage ( Figures 4A,C) . This consisted of the presence of an arteriolar tree pathological in 17 out of 28 patients in the venogenic (60%) and in 19 out of 29 patients in the mixed group (65%); the helicine arterioles were characterized by a reduced caliber and one order of distal rami®cations originating with a right angle from the main trunk of the cavernous artery in both groups. The picture of arteriolar damage was characteristic of elderly patients (mean age 63 AE 3 y) that referred the presence of vascular risk factorsÐcoronary heart disease andaor hypertensionÐ(n 12), cigarette smoking (n 16) or diabetes (n 8).
No case of priapism occurred with the agents and the doses used in this study. Three patients (3.3% out of total number of patients who performed re-dosing) had prolonged erections ( b 2 h) and were treated with 500 mg intracavernous metharaminol which led to a prompt detumescence. These patients were all of the psychogenic group: two of them 
Discussion
Dynamic color power Doppler (CPD) sonography allows for the precise evaluation and characterization in power energy of the cavernosal arteries, and a speci®ed visualization of the pattern of the helicine arterioles along most of the penile crura and the entire penile shaft. The measurements of peak systolic velocity to evaluate arterial in¯ow, the end diastolic velocity and the resistive index [(peak systolic velocity) 7 (end diastolic velocity)a(peak systolic velocity)] to evaluate the cavernous venoocclusive function, represent the least invasive and more sensitive diagnostic approach in men affected by erectile dysfunction. 14 ± 16 However, complete smooth muscle relaxation is not always achieved in the of®ce setting, and this may be due to the presence of anxiety that causes a hypersecretion of catecholaminesÐnorepinephrine and epinephrineÐinto penile circulation in both non organic 9 and organic 17 impotent patients. Catecholamines are known to inhibit maximal erectile response to pharmacotesting, 18 probably due to the activation of central (via opioids) and peripheral (via hypothalamic-pituitary adrenal axis) inhibitory neuroendocrine responses, respectively. 19, 20 A standard intracavernous test dosage has never been established for any agent. Contemporary hemodynamic investigations suggest that a positive pharmacotesting is associated with normal veno-occlusion (low¯ow to maintain erection values of 0.5 ± 3 mlamin and minimal contrast medium or no contrast leakage during cavernosometry-cavernosography) but not necessarily with normal arterial function. 21, 22 To optimize the accuracy of pharmacotesting, Donatucci and Lue ®rst demonstrated that the combination of injection plus manual genital self-stimulation Figure 4 Venogenic and mixed ED responders to vasoactive challenge. Power Doppler sonography after 10 mcg PGE 1 (A, C) and after redosing of 10 mcg PGE 1 plus 1 mg PHE (B, D). After challenge of PGE 1 alone, only one order of distal rami®cations of helicine arterioles was visualized; after re-dosing of PGE 1 plus PHE two orders of distal rami®cations were evident and semirigid and sustained erections were obtained despite a non uniform arteriolar caliber. PGE 1 plus phentolamine and penile power Doppler sonography A Aversa et al leads to a higher rate of rigid erections compared to injection alone. 23 Other authors found that dynamic color Doppler sonography should be performed after injection plus genital and audio-visual sexual stimulation (AVSS); 3 also, in subsequent studies they showed that re-dosing of PGE 1 should always be performed when an incomplete erectile response occurs after the injection plus stimulation phase to evaluate the presence of false negative responders. 10 Other authors suggested that in order to standardize the genital stimulation, vibrotactile devices should be used. 24 Even if 10 mg PGE 1 has been proposed as the ®rst injection dose, there is no consensus on the drug and doses that should be used for re-dosing. Re-dosing of trimix has been shown to be of value in predicting arterial dysfunction; however, it has a limited role in investigating the veno-occlusive mechanism, due to the necessity of using low doses of each single agent in order to prevent prolonged erections and priapism which can occur at high frequency with this mixture. 17, 25 This study provides for the ®rst time penile blood¯ow-based evidence that re-dosing of a combination of PGE 1 and phentolamine has a better diagnostic sensitivity than re-dosing of PGE 1 alone with a comparable pro®le of safety. We had no cases of priapism since we decided to interrupt all prolonged erections b2 h by injecting intracavernously the antidote metaraminol. This is based upon the knowledge that prolonged erection-induced hypoxia and subsequent local acidosis impair contractility of trabecular smooth muscles impeding the drainage of blood, perpetuating the ischemic state and causing early ultrastructural changes. 26, 27 Furthermore it is established that reversal of prolonged erectiona priapism is promptly obtained with the use of alpha-agonists, such as metaraminol, the soonest it is performed. 28 In our study only three out of 90 subjects had prolonged erections; these patients were young otherwise healthy subjects and all in the psychogenic group. In all of them a rapid and safe detumescence was obtained within 5 min after the injection of 500 mcg metaraminol.
The design of our study compared two regimes of unequal strength and this could be a potential bias. However, in a previous study we carried out doubleblind experiments by using a higher dosage of PGE 1 alone (25 mgaml) or in combination with the same dose of phentolamine and demonstrated that the latter mixture caused a comparable degree of increase in the percentage of subjects responding to pharmacotesting. 9 These results are consistent with the hypothesis that the addition of some phentolamine may overcome anxiety-induced inhibition of erectile response to ICI with a maximal dose of PGE 1 alone. In the present study, 10 mg PGE 1 plus AVSS failed to induce a complete erectile response in about 40% of psychogenic patients; however, after re-dosing plus AVSS, the combination of PGE 1 and phentolamine led to 86% of responders versus 43% with PGE 1 alone. Furthermore, in most of these patients a characteristic picture became evident at CPD study which consisted in the visualization of helicine arterioles with three orders of distal rami®cations versus two orders of rami®cations observed after phase 1. 29 It is conceivable that the addition of phentolamine relaxed the constricted arterioles of patients with high levels of anxiety before the test by interacting with the numerous alpha-adrenergic receptors present in the trabecular tissue and cavernous vessels, 30 and eventually by corporal relaxation of smooth muscle cells through the synergistic activation of a non-adrenergic nitric-oxide mediated pathway. 31 As expected, none of the venogenic and mixed arterious-venogenic patients (n 90) reached a rigid erection after phase 1 (RI`0.90); however, after phase 2, re-injection caused the appearance of a semirigid erection (RI b 0.90) in a subset of subjects with organic ED further indicating that re-dosing is recommended also when veno-occlusive is suspected. 5, 17 Interestingly, in both groups of patients the erectile response as well as Doppler parameters were magni®ed more than 3-fold by re-dosing of PGE 1 plus phentolamine (39% versus 12% and 21% versus 6%, respectively); this suggests that phentolamine improves the diagnostic ef®cacy of dynamic CPD studies possibly by speci®c unmasking a subset of impotent patients with increased adrenergic tone due to concomitant emotional disturbances. 9, 32 In these patients, it is likely that the mild corporeal veno-occlusive dysfunction may be suf®ciently and satisfactorily treated with sildena®l 50 ± 100 mg at home. 33 In the majority of venogenic and mixed arterio-venogenic impotent patients not responding to re-dosing, CPD studies showed an arteriolar damage consisting of the presence of helicine arterioles with only one order of distal rami®cations originating from the main trunk with a prevalent right angle, and a narrow and nonuniform caliber. By contrast, in responders to redosing CPD studies evidenced helicine arterioles with two orders of distal rami®cations mainly originating with a prevalent acute angle from the cavernous artery, which was consistent with a lesser degree of arteriolar damage 5, 29 and explained the greater clinical erectile response. Gross arteriolar damage was typical of impotent subjects above 60, who referred the presence of concomitant vascular risk factors, cigarette smoking or diabetes. These patients did not respond either to re-dosing of PGE 1 or PGE 1 plus phentolamine.
Arteriogenic patients showed no improvement of penile hemodynamic parameters recorded with CPD sonography during phase 2 of the study as well as no signi®cant changes in the degree of erection; they did not present any side effect after re-dosing such as prolonged erection. A low PGE 1 dosage was suf®cient for obtaining an accurate penile blood ow study. The four arteriogenic patients who responded to phase 1 had valid communicating PGE 1 plus phentolamine and penile power Doppler sonography A Aversa et al arteries (two patients) despite low PSVs and a normal con®guration of helicine arterioles (two patients) at CPD study, thus explaining the presence of full erection. 12, 29 By contrast, non-responders showed altered microcirculation features in accordance with other authors' ®ndings 5 and no valid arterial shunts.
Color power-Doppler sonography identi®es penile microcirculation features not otherwise visible by color Duplex ultrasound and represents a safe, speci®c and well tolerated procedure. However, the presence of anxiety in the of®ce setting can inhibit erection and lead to false positive diagnosis of corporeal veno-occlusive dysfunction. 9 Our ®ndings clearly indicate that when pharmacoerection testing with a PGE 1 alone is inef®cacious, re-dosing of PGE 1 plus phentolamine followed by audiovisual sexual stimulation could be a valid alternative instead of repetition of CPD sonography, 34 independently from the etiology of ED.
Conclusions
In conclusion, overall impotent patients who underwent re-dosing were of comparable number to detect differences in the ef®cacy of each re-dose test used: 45 patients in phase 2a and 45 patients in phase 2b. In the PGE 1 re-dose group, 15% of patients upgraded their erection whereas in the cocktail re-dose group 35% of patients had erectile responses better than that obtained at home. CPD studies sustained and explained the clinical results. We are aware of the caveats of color-power Doppler sonography in the diagnosis of impotence and that its application is still limited to research protocols or in eventual candidates to reconstructible vascular disease. However in the near future we do believe that this technique would not be considered only investigational based upon the evolutionary concepts of new software such as digitalized bi-directional powerDoppler and concomitant use of contrast media, that will allow for an event better diagnostic sensitivity of penile microcirculation features in unexplained erectile dysfunction. The RI measured when maximal response to vasodilator challenge has occurred seems to be an accurate predictor of cavernous artery in¯ow and venous leakage in male erectile dysfunction, when compared to more invasive diagnostic techniques such as dynamic infusion cavenosometry-cavernosography and angiography, 15 that should be reserved only for selected cases not responding to the ®rst-line diagnostic testing. 
